On August 26, 2022, Humanigen, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired the Company’s securities between May 28, 2021 and July 12, 2022.
Recent Security Class Actions
On August 25, 2022, Dingdong (Cayman) Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s American Depositary Shares (“ADS”) in or traceable to the Company’s June 2021 initial public offering.
On August 25, 2022, NIO Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s securities between March 1, 2021 and July 11, 2022.
On August 23, 2022, Bed Bath & Beyond Corporation was sued for violations of the federal securities laws in the United States District Court for the District of Columbia on behalf of investors who purchased or otherwise acquired the Company’s shares between March 25, 2022 and August 18, 2022.
On August 19, 2022, Lottery.com was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s securities between November 15, 2021 and July 29, 2022.
On August 17, 2022, MINISO Group Holding Limited was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired the Company’s publicly traded securities in or traceable to the Company’s October 2020 initial public offering.
On August 17, 2022, Ampio Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased the Company’s shares between December 29, 2020 and August 3, 2022.
On August 16, 2022, Co-Diagnostics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s publicly traded securities between May 12, 2022 and August 11, 2022.
On August 16, 2022, Uber Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s shares between May 31, 2019 and July 8, 2022.
On August 10, 2022, LifeStance Health Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s shares pursuant and/or traceable to the Company’s June 2021 initial public offering (the “IPO”).
On August 9, 2022, Tuya Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s American Depositary Shares (“ADSs”) in or traceable to the Company’s March 2021 initial public offering.
On August 5, 2022, Kiromic BioPharma was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired: (a) Kiromic common stock pursuant to the July 2021 public offering and/or (b) Kiromic common stock between June 25, 2021 and August 13, 2021.
On August 4, 2022, Coinbase Global was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired the Company’s publicly traded securities between April 14, 2021 and July 26, 2022, inclusive (the “Class Period”).
On August 03, 2022, Carvana Co. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired the Company’s publicly traded securities between May 6, 2020 and June 24, 2022, inclusive (the “Class Period”).
On July 29, 2022, Weber Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of investors who purchased or otherwise acquired Weber Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2021 initial public offering.
On July 26, 2022, Enochian Biosciences Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased the Company’s securities between September 24, 2020 and May 31, 2022.
On July 19, 2022, 17 Education & Technology Group Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired publicly traded 17EdTech securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with 17EdTech December 2020 initial public offering.
On July 18, 2022, TG Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s securities between January 15, 2020 and May 31, 2022.
On July 12, 2022, Molecular Partners was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired: (a) Molecular Partners American Depositary Shares (“ADSs”) pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about June 16, 2021 (the “IPO”); and/or (b) Molecular Partners securities between June 16, 2021 and April 26, 2022, both dates inclusive (the “Class Period”).
On July 12, 2022, Missfresh was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities in or traceable to the Company’s June 2021 initial public offering (the “IPO”).
